Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tamsulosin: current clinical experience.

M P O'Leary1

  • 1Division of Urologic Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Urology
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fractured penis: a review.

International journal of impotence research·2008
Same author

Dutasteride significantly improves quality of life measures in patients with enlarged prostate.

Prostate cancer and prostatic diseases·2007
Same author

Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2006
Same author

Distribution of the Brief Male Sexual Inventory in community men.

International journal of impotence research·2003
Same author

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor.

BJU international·2003
Same author

Early ejaculation.

BJU international·2003

Benign prostatic hyperplasia (BPH) causes common lower urinary tract symptoms (LUTS) in aging men. Tamsulosin offers effective, well-tolerated relief for LUTS from BPH, with rapid and durable improvements.

Area of Science:

  • Urology
  • Pharmacology
  • Epidemiology

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition in aging men.
  • Lower urinary tract symptoms (LUTS) significantly impact daily living and cause worry.
  • Pharmacologic agents, particularly alpha-adrenergic antagonists, are a primary treatment for LUTS associated with BPH.

Purpose of the Study:

  • To review the epidemiology and natural history of BPH.
  • To discuss the role of alpha-adrenergic antagonists in managing LUTS.
  • To highlight the efficacy, safety, and administration advantages of tamsulosin compared to other alpha blockers.

Main Methods:

  • Review of population-based studies on BPH epidemiology and LUTS.
  • Analysis of pharmacologic data for alpha-adrenergic antagonists.

Related Experiment Videos

  • Comparison of tamsulosin's properties with conventional alpha blockers like terazosin and doxazosin.

    • Main Results:

    • Moderate-to-severe LUTS are prevalent and disruptive in aging men.
    • Tamsulosin selectively targets alpha(1A)-adrenergic receptors, offering comparable efficacy to conventional alpha blockers.
    • Tamsulosin demonstrates advantages in safety, tolerability, and administration, including no need for titration and rapid onset of action.

    Conclusions:

    • Tamsulosin provides rapid, durable improvements in LUTS and urinary flow rates for BPH.
    • Its subselective and pharmacodynamic properties may offer enhanced safety and tolerability.
    • Tamsulosin represents a significant advancement in the pharmacologic management of LUTS due to BPH.